272
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab with or Without Transhepatic Arterial Embolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and High Tumor Burden: A Multicenter Retrospective Study

, , , , , , , , , , , , , & show all
Pages 1209-1222 | Received 04 May 2023, Accepted 10 Jul 2023, Published online: 27 Jul 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (1)